Back to Awarded Treatment Trials
Awarded Trial: 01T-107
Grant ID
01T-107
Illness
Schizophrenia
Primary Drug/Intervention
Gingko Biloba
Primary Dosage
360 mg
Secondary Drug Intervention
N/A
Secondary Dosage
N/A
Other Drug/Intervention
N/A
Other Dosage
N/A
Status
Completed
Investigator
Cheung
Sample Size
57
Duration of Study Period for Each Subject
12 weeks
Outcome Measurements
PANSS, SANS, CGI, Cognitive battery
Results
Fifty seven patients were randomized and 47 completed the 12 week trial. There were no significant differences between Gingko Biloba and placebo on psychiatric symptom ratings or measures of cognition.
Publication
N/A
Link
N/A
PI Name
Freda Cheung
Degree
MD
Center
Harbor-UCLA Research & Education Institute
Institution
Los Angeles Biomedical Research Intitute
Address
1124 W. Carson St, B-4 South
City or Town
Torrance
State or Province
CA
Zip or Postal Code
90502
Country
USA
Email Address
fcheung@labiomed.org